Webinar: Current Urologic Management of Female Sexual Dysfunction (2020)

June 11, 2020

Course Director: Irwin Goldstein, MD

This course will teach the urologist and advanced practice provider the skills needed to better communicate with the female patient about her sexual health needs and better manage her sexual dysfunctions. The course will start with normal physiology and pathophysiology of the genitals including how to examine them under magnification in order to better understand sexual dysfunctions in women. Diagnostic tools and treatment strategies for the management of desire, arousal, orgasm and pain disorders including unusual arousal/orgasm issues such as persistent genital arousal disorder will be discussed.

Included in this course is an overview of to use the latest FDA approved drugs, off label options, devices such as CO2 fractional laser and surgical therapies. Women with distressing sexual health concerns should undergo biopsychosocial diagnostic evaluations to assess pathophysiology, starting with a history and physical with vulvoscopy. Risks and benefits of hormone therapy for pre- and post-menopausal women will be included, as well as information about neurologic issues affecting sexual function. Also discussed are risk factors for female sexual dysfunction and co-morbid conditions such as genitourinary syndrome of menopause, interstitial cystitis and sexual dysfunction, clitoral phimosis and previous genital surgeries including mid-urethral surgical slings. Women presenting with urologic concerns may, in fact, have sexual dysfunction as the primary issue.

Please note this course is FREE to all AUA Members and is an exclusive member benefit.  If you would like to become an AUA Member, we'd be happy to have you - think about all the great member benefits!

Target Audience

  • Urologists
  • Residents
  • Advanced Practice Providers (Nurse Practitioners and Physician Assistants)

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Associate basic science principles with physiology and pathophysiology of female sexual function and dysfunction.
  2. Apply principles of history and physical examination to the woman with sexual dysfunction.
  3. Characterize the consensus paradigms for identification of sexual problems in women, hypoactive sexual desire disorder, and persistent genital arousal disorder developed by the International Society for the Study of Women’s Sexual Health.
  4. Diagnose and treat woman with sexual dysfunction presenting in a community setting with FDA-approved and off label medical therapies including estrogen (and progesterone) and androgen therapies as well as centrally-acting drugs.
  5. Identify when sexual pain should be treated surgically.
Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Non-Physician Participation
Course opens: 
05/28/2020
Course expires: 
06/11/2023
Event starts: 
06/11/2020 - 7:00pm EDT
Event ends: 
06/11/2020 - 8:30pm EDT
Rating: 
0

Scientific Agenda

7:00-7:02             Welcome & Housekeeping - AUA

7:02-7:05             Webinar/Faculty Introduction – Irwin Goldstein, MD

7:05-7:20             Physiology, Pharmacology and Pathophysiology - Noel Kim, PhD

7:20-7:28             History and Physical Examination - Rachel Rubin, MD

7:28-7:40             Medical Management of Sexual Pain - Rachel Rubin, MD

7:40-7:52             Medical Management of HSDD - Ashley Winter, MD

7:52-8:15             Management of Arousal/Orgasm Disorders; Surgical Management  of Sexual Pain Disorders - Irwin Goldstein, MD

 8:15-8:30            Q & A

Current Urologic Management of Female Sexual Dysfunction (2020) will be held virtually on Thursday, June 11 at 7 PM EST. 

***Instructions***

  1. Click the "Register" tab.
  2. If prompted, click “update your profile”. Otherwise, click “Take Course”.
  3. Click “Start” under Live Webinar in the Course Progress pane.
  4. Click "Join Webinar".

Education Council Disclosures

PDF icon Education Council Disclosures

AUA Office of Education Staff has nothing to disclose.

 

 

Course Director(s)

Irwin Goldstein, MD

has a financial relationship (Other) with TRT;.
has a financial relationship (Other) with BTL;.
has a financial relationship (Independent contractor) with Pfizer;.
has a financial relationship (Other) with AbbVie;.
has a financial relationship (Other) with Marius ;.
has a financial relationship (Other) with BTL;.
has a financial relationship (Other) with Tissue Genesis;.
has a financial relationship (Independent contractor) with Strategic Science & Technologies;.
has a financial relationship (Independent contractor) with Ipsen;.
has a financial relationship (Other) with Plethora;.
has a financial relationship (Independent contractor) with Morari;.
has a financial relationship (Other) with Endoceutics;.
has a financial relationship (Other) with Cynosure;.
has a financial relationship (Independent contractor) with International Society for Sexual Medicine;.
has a financial relationship (Independent contractor) with Trophikos;.
has a financial relationship (Independent contractor) with Coloplast Corporation;.
has a financial relationship (Other) with AMAG Pharmaceuticals;.
Faculty(s)

Noel Kim, PhD

has a financial relationship (Independent contractor) with San Diego Sexual Medicine;.
has a financial relationship (Independent contractor) with San Diego Sexual Medicine;.
has a financial relationship (Independent contractor) with Sprout Pharmaceuticals;.
has a financial relationship (Independent contractor) with Strategic Science and Technologies;.
has a financial relationship (Independent contractor) with Strategic Science and Technologies;.
has a financial relationship (Independent contractor) with Sprout Pharmaceuticals;.

Rachel Rubin, MD

has a financial relationship (Other) with IPSEN;.
has a financial relationship (Other) with Endoceutics ;.
has a financial relationship (Other) with IPSEN;.
has a financial relationship (Other) with Endoceutics ;.
has a financial relationship (Other) with Bayer Healthcare;.
has a financial relationship (Other) with Abbvie;.
has a financial relationship (Other) with Bayer Healthcare;.
has a financial relationship (Other) with Abbvie;.

Ashley Winter, MD

has no relevant financial relationships to disclose at this time.

ACCREDITATION: 

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: 

The American Urological Association designates this live activity for a maximum of 1.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER LEARNERS: 

The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

EVIDENCE BASED CONTENT: 

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA DISCLOSURE POLICY: 

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST: 

All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group for identification of conflicts of interest. The AUA COI Review Work Group, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or AUA COI Review Work Group.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES: 

The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.


AUA Participant Information and Policies

DISCLAIMER:

The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

AUDIO, VIDEO AND PHOTOGRAPHIC EQUIPMENT:

The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meetings.

REPRODUCTION PERMISSION: 

Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

SPECIAL ASSISTANCE/DIETARY NEEDS:

The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Non-Physician Participation
Please login or register to take this course.

To join the webinar:

  1. Click on the TAKE COURSE button.
  2. Click “Start” under Live Webinar in the Course Progress pane.
  3. Click "Join Webinar".